Company: STAA
Filing Date: 2025-11-10
Form Type: DFAN14A
Source: 0001213900-25-108281
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-11-10
Form: DFAN14A
Chunk 2
---
ITIONAL INFORMATION RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The definitive proxy statement
and an accompanying GREEN Proxy Card will be furnished to some or all of the Company’s stockholders and will be,
along with other relevant documents, available at no charge on the SEC’s website at https://www.sec.gov/.

Information about the Participants and a description of their direct
or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants with
the SEC on October 24, 2025 and is available here.

Exhibit 1

<div align='center'>Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

Believes New, Independent, and Experienced Directors Are Needed in Order to Restore Trust in the Board and Confidence in the Go-Shop Process

Notes Recently Appended Go-Shop Is Not a Good Substitute for a Full Strategic Alternatives Process Conducted at the Right Time</div>

NEW YORK--()--Broadwood Partners,
L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement
in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon
Inc. (“Alcon”) (NYSE: ALC).

Neal C. Bradsher, Founder and President of Broadwood,
said:

“For more than three months, we
have been telling the Board of Directors that its decision to sell STAAR to Alcon came at the wrong time, resulted from the wrong process,
and was at the wrong price. The vast majority of shareholders and all three major proxy advisory firms shared our perspective and overwhelmingly
opposed this misbegotten transaction.

We are pleased that the Board now recognizes
– albeit belatedly – the flaws in its initial process, including with respect to timing, and acknowledges the benefits of
a wider solicitation of proposals. However, as we have pointed out for months, ‘window shops’ and ‘go-shops’ are
never good substitutes for a well-designed, well-timed, thorough sale process.

One thing we are certain of: shareholders
will have little confidence in the outcome of this ‘go-shop’ if the same directors, bankers, and lawyers who designed and
executed an inappropriate and flawed sale process in the first place remain in exclusive control of these new pall